PMID- 10696121 OWN - NLM STAT- MEDLINE DCOM- 20000321 LR - 20190905 IS - 0098-1532 (Print) IS - 0098-1532 (Linking) VI - 34 IP - 3 DP - 2000 Mar TI - Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study. PG - 165-70 AB - BACKGROUND: Hepatoblastoma (HBT) is the most common hepatic neoplasm in children. This notwithstanding, little is known about pathogenetic factors, such as genetic abnormalities, of importance for the development and progression of this tumor type. To date, only 33 cytogenetically abnormal HBT have been published, and trisomies for chromosomes 2 and 20 have been shown to be the most frequent aberrations. Recently, unbalanced translocations involving proximal 1q have been described in several HBT, suggesting that a pathogenetically important gene maps to 1q. PROCEDURE: Six primary and one recurrent HBT were cytogenetically analyzed after short-term tissue culture. In addition, fluorescence in situ hybridization (FISH) studies, using locus-specific probes, were performed on three of these pediatric HBT as well as on one previously reported adult HBT. RESULTS: Total or partial trisomy 8, gain of chromosome 20, and structural rearrangements of chromosome 1 were detected in three HBT, and overrepresentation of chromosome 2 material was found in two HBT. The adjacent chromosome bands 1q12 and 1q21 were involved in three translocations, t(1;2), t(1;4), and t(1;11), which were all unbalanced and resulted in gain of 1q material. The previously reported adult HBT displayed 1q deletions with breakpoints at 1q12-21. FISH analyses of the 1q rearrangements revealed that all breakpoints were within the heterochromatic region. CONCLUSIONS: These findings provide further support for the importance of trisomies 2, 8, and 20 and rearrangements of 1q in the development of HBT. Furthermore, the consistent localization of breakpoints within the heterochromatic segment of chromosome 1 suggests that the important pathogenetic consequence of 1q abnormalities is the resulting genomic imbalance rather than a specific gene rearrangement. FAU - Parada, L A AU - Parada LA AD - Department of Clinical Genetics, University Hospital, Lund, Sweden. FAU - Limon, J AU - Limon J FAU - Iliszko, M AU - Iliszko M FAU - Czauderna, P AU - Czauderna P FAU - Gisselsson, D AU - Gisselsson D FAU - Hoglund, M AU - Hoglund M FAU - Kullendorff, C M AU - Kullendorff CM FAU - Wiebe, T AU - Wiebe T FAU - Mertens, F AU - Mertens F FAU - Johansson, B AU - Johansson B LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't PL - United States TA - Med Pediatr Oncol JT - Medical and pediatric oncology JID - 7506654 SB - IM MH - Child, Preschool MH - Chromosome Banding MH - Chromosomes, Human, Pair 1/*genetics MH - Chromosomes, Human, Pair 20/genetics MH - Chromosomes, Human, Pair 8/genetics MH - Female MH - Gene Rearrangement/*genetics MH - Hepatoblastoma/*genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Infant MH - International Cooperation MH - Karyotyping MH - Liver Neoplasms/*genetics MH - Male MH - Trisomy/genetics EDAT- 2000/03/01 09:00 MHDA- 2000/03/25 09:00 CRDT- 2000/03/01 09:00 PHST- 2000/03/01 09:00 [pubmed] PHST- 2000/03/25 09:00 [medline] PHST- 2000/03/01 09:00 [entrez] AID - 10.1002/(SICI)1096-911X(200003)34:3<165::AID-MPO1>3.0.CO;2-T [pii] AID - 10.1002/(sici)1096-911x(200003)34:3<165::aid-mpo1>3.0.co;2-t [doi] PST - ppublish SO - Med Pediatr Oncol. 2000 Mar;34(3):165-70. doi: 10.1002/(sici)1096-911x(200003)34:3<165::aid-mpo1>3.0.co;2-t.